Results 171 to 180 of about 79,473 (337)
This real‐world multicenter study assessed the short‐term effectiveness and safety of mirikizumab induction therapy in ulcerative colitis patients. Among 52 patients, the median partial Mayo score significantly decreased from week 0 to 12, and 44.2% achieved clinical remission, with no treatment‐related discontinuations or deaths.
Yasuhiro Takagi+14 more
wiley +1 more source
Long-term results of medical treatment in patients with a severe attack of ulcerative colitis
Aim. To assess the long-term result of medical treatment in patients with a severe attack (SA) of ulcerative colitis (UC). Subjects and methods. The course of UC was analyzed in 56 patients who were accessible by telephone contact and consecutively ...
I L Khalif+3 more
doaj
Abstract Aim The incidence of colorectal carcinoma (CRC) in transplant (TX) recipients is higher than in the general population. Registry data indicate inferior oncological outcomes for this population. While the general surgical risk is increased in TX recipients, the risk associated with elective CRC surgery in this population is not well ...
Phil Meister+5 more
wiley +1 more source
Outcome of colectomy for severe idiopathic constipation. [PDF]
Michael A. Kamm+2 more
openalex +1 more source
ABSTRACT Background and Aim Vedolizumab (VDZ) is often used in older patients with ulcerative colitis (UC) in clinical practice; however, real‐world evidence is still limited, including in those with late‐onset UC. Methods This post hoc analysis of a multicenter, retrospective, observational chart review, enrolling 370 patients with UC receiving VDZ ...
Tadakazu Hisamatsu+21 more
wiley +1 more source
Adverse relationship between blood transfusions and survival after colectomy for colon cancer [PDF]
Roger S. Foster+4 more
openalex +1 more source
Intestinal Obstruction Following Total Colectomy for Ulcerative Colitis*
G. E. Tolstedt, Jonathan Bell
openalex +2 more sources